American Healthcare REIT, Inc. (AHR) Stock Forecast
Alert
Its only available to paid users.
USD 22.75
(-8.60%)
Based on the American Healthcare REIT, Inc. stock forecast from 6 analysts, the average analyst target price for American Healthcare REIT, Inc. is USD 22.75 over the next 12 months. American Healthcare REIT, Inc.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of American Healthcare REIT, Inc. is Slightly Bullish , which is based on 4 positive signals and 3 negative signals. At the last closing, American Healthcare REIT, Inc.’s stock price was USD 24.89. American Healthcare REIT, Inc.’s stock price has changed by -0.16% over the past week, -3.08% over the past month and 0% over the last year.
No recent analyst target price found for American Healthcare REIT, Inc.
No recent average analyst rating found for American Healthcare REIT, Inc.
Company Overview American Healthcare REIT, Inc.
American Healthcare REIT, Inc. is a self-managed real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties, focusing primarily on outpatient medical buildings, senior housing, skilled nursing facilities and other healthcare-related facilities. Its properties are located in 36 states, the United Kingdom and the Isle of Man. Address: 18191 Von Karman Avenue, Irvine, CA, United States, 92612-7106 Read Less
American Healthcare REIT, Inc. is a self-managed real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties, focusing primarily on outpatient medical buildings, senior housing, skilled nursing facilities and...Read More
N/A
N/A
122
N/A
USD
USA
Adjusted Closing Price for American Healthcare REIT, Inc. (AHR)
Loading...
Unadjusted Closing Price for American Healthcare REIT, Inc. (AHR)
Loading...
Share Trading Volume for American Healthcare REIT, Inc. Shares
Loading...
Compare Performance of American Healthcare REIT, Inc. Shares
Frequently Asked Questions About American Healthcare REIT, Inc. (AHR) Stock
Based on ratings from 6 analysts American Healthcare REIT, Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 14 buy, sell and hold ratings.
AHR stock's dividend yield is 4.07%.
Our analysis grades AHR stock's dividend yield at F. This means that AHR stock's dividend yield is above 40% of the stocks in the REIT - Healthcare Facilities sector in the NYE exchange.
Based on this AHR may be a average dividend stock for its sector.
Based on targets from 6 analysts, the average taret price for AHR is USD 22.75 over the next 12 months. The maximum analyst target price is USD 31 while the minimum anlayst target price is USD 16.
Unfortunately we do not have enough data on AHR's stock to indicate if its overvalued.
The last closing price of AHR's stock was USD 24.89.
The most recent market capitalization for AHR is USD 3.76B.
Based on targets from 6 analysts, the average taret price for AHR is projected at USD 22.75 over the next 12 months.
This means that AHR's stock price may go down by -8.60% over the next 12 months.
We can't find any ETFs which contains American Healthcare REIT, Inc.'s stock.
As per our most recent records American Healthcare REIT, Inc. has 122 Employees.
Sorry we do not have any infomation available on American Healthcare REIT, Inc.'s address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About American Healthcare REIT, Inc. (AHR) Stock
Based on ratings from 6 analysts American Healthcare REIT, Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 14 buy, sell and hold ratings.
AHR stock's dividend yield is 4.07%.
Our analysis grades AHR stock's dividend yield at F. This means that AHR stock's dividend yield is above 40% of the stocks in the REIT - Healthcare Facilities sector in the NYE exchange.
Based on this AHR may be a average dividend stock for its sector.
Based on targets from 6 analysts, the average taret price for AHR is USD 22.75 over the next 12 months. The maximum analyst target price is USD 31 while the minimum anlayst target price is USD 16.
Unfortunately we do not have enough data on AHR's stock to indicate if its overvalued.
The last closing price of AHR's stock was USD 24.89.
The most recent market capitalization for AHR is USD 3.76B.
Based on targets from 6 analysts, the average taret price for AHR is projected at USD 22.75 over the next 12 months.
This means that AHR's stock price may go down by -8.60% over the next 12 months.
We can't find any ETFs which contains American Healthcare REIT, Inc.'s stock.
As per our most recent records American Healthcare REIT, Inc. has 122 Employees.
Sorry we do not have any infomation available on American Healthcare REIT, Inc.'s address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AHR !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
